Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wayne

Showing results (361-370 of 400) with videos related to

Pageof 40
Sort By:
Leukemia|August 27, 2010
High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemiasS Morisot, A S Wayne, O Bohana-Kashtan, et al.
ACS Chemical Neuroscience|September 15, 2015
Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198)Steven D Chang, Lawrence E Brieaddy, Joseph D Harvey, et al.
Journal of Medicinal Chemistry|July 26, 2002
Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphansJames B Thomas, Robert N Atkinson, Nivedita Namdev, et al.
Nature|March 23, 2012
Structure of the human κ-opioid receptor in complex with JDTicHuixian Wu, Daniel Wacker, Mauro Mileni, et al.
Pediatric Blood & Cancer|September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reductionNirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Addiction (Abingdon, England)|January 10, 2013
Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trialS Wayne Miles, Janie Sheridan, Bruce Russell, et al.
Pediatric Blood & Cancer|June 21, 2022
Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortiumEric S Schafer, Karen Chao, Alexandra M Stevens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Thoracic Cancer|June 16, 2025
Optimizing Pre-Operative Clinical Staging in Resectable Non-Small Cell Lung Cancer (NSCLC): A Retrospective Cohort StudyE Samuel, C Thomas, C Thompson, et al.
Blood Cancer Discovery|December 3, 2024
CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T CellsSamy Jambon, Jianping Sun, Shawn Barman, et al.
Pageof 40

Showing results (361-370 of 400) with videos related to

Sort By:
Pageof 40
Leukemia|August 27, 2010
High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemiasS Morisot, A S Wayne, O Bohana-Kashtan, et al.
ACS Chemical Neuroscience|September 15, 2015
Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198)Steven D Chang, Lawrence E Brieaddy, Joseph D Harvey, et al.
Journal of Medicinal Chemistry|July 26, 2002
Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphansJames B Thomas, Robert N Atkinson, Nivedita Namdev, et al.
Nature|March 23, 2012
Structure of the human κ-opioid receptor in complex with JDTicHuixian Wu, Daniel Wacker, Mauro Mileni, et al.
Pediatric Blood & Cancer|September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reductionNirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Addiction (Abingdon, England)|January 10, 2013
Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trialS Wayne Miles, Janie Sheridan, Bruce Russell, et al.
Pediatric Blood & Cancer|June 21, 2022
Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortiumEric S Schafer, Karen Chao, Alexandra M Stevens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Thoracic Cancer|June 16, 2025
Optimizing Pre-Operative Clinical Staging in Resectable Non-Small Cell Lung Cancer (NSCLC): A Retrospective Cohort StudyE Samuel, C Thomas, C Thompson, et al.
Blood Cancer Discovery|December 3, 2024
CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T CellsSamy Jambon, Jianping Sun, Shawn Barman, et al.
Pageof 40